4.5 Article

Progress towards elimination of mother-to-child transmission of hepatitis B virus infection in China: a modelling analysis

期刊

出版社

WORLD HEALTH ORGANIZATION
DOI: 10.2471/BLT.19.248146

关键词

-

资金

  1. United Nations International Children's Emergency Fund (UNICEF) China office [602033]
  2. Chinese Ministry of Science and Technology Program for Important Infectious Diseases Control and Prevention [2017ZX10105015, 2018ZX10721202]
  3. MRC [MR/R015600/1] Funding Source: UKRI

向作者/读者索取更多资源

By developing a dynamic model, it was projected that China will achieve the elimination target of HBV MTCT by 2029 if current prevention interventions are maintained. Increasing coverage of birth-dose vaccination can bring the target forward to 2025, while the administration of tenofovir to HBeAg-positive pregnant women can bring it forward to 2024. Predicting a MTCT rate of less than 2% in 2020 would help achieve the target by 2025.
Objective To determine the projected burden of hepatitis B virus (HBV) in China, the intervention strategies that can eliminate mother-to-child transmission (MTCT) by 2030 or earlier and the measurable parameters that can be used to monitor progress towards this target. Methods We developed a dynamic, sex- and age-stratified model of the HBV epidemic in China, calibrated using hepatitis B surface antigen (HBsAg) and e antigen (HBeAg) prevalence data from sequential national serosurveys (1979-2014) and the numbers of HBV-related cancer deaths (2012). We determined whether China can achieve elimination of MTCT of HBV by 2030 under current prevention interventions. We modelled various intervention scenarios to represent different coverage levels of birth-dose HBV vaccination, hepatitis B immunoglobulin to newborns of HBsAg-positive mothers and antiviral therapy (tenofovir) to HBeAg-positive pregnant women. Findings We project that, if current levels of prevention interventions are maintained, China will achieve the elimination target by 2029. By modelling various intervention scenarios, we found that this can be brought forward to 2025 by increasing coverage of birth-dose vaccination, or to 2024 by the administration of tenofovir to HBeAg-positive pregnant women. We found that achievement of the target by 2025 would be predicted by a measurement of less than 2% MTCT in 2020. Conclusion Our results highlight how high-quality national data can be combined with modelling in monitoring the elimination of MTCT of HBV. By demonstrating the impact of increased interventions on target achievement dates, we anticipate that other high-burden countries will be motivated to strengthen HBV prevention policies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据